Stockreport

Cytokinetics to get up to $575M in funding from Royalty Pharma [Seeking Alpha]

Cytokinetics, Incorporated  (CYTK) 
Last cytokinetics, incorporated earnings: 3/3 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytokinetics.com/investor-overview
PDF upfront, to support commercialization of Cytokinetics' drug aficamten and advancement of its pipeline. Under the deal, Cytokinetics will receive $50M for the commercia [Read more]